CompanyDrug

Immorna’s JCXH-221 mRNA Vaccine Cleared by FDA for Phase I/II Study

CompanyDeals

Henlius Biotech Partners with Shantou Central Hospital for Clinical Study Collaboration

CompanyMedical Device

AnchorDx Initiates US Registrational Study for UriFind Urothelial Carcinoma Diagnostic

CompanyR&D

Biocytogen Announces Successful Development of Fully-Human Nano Antibody RenNano

CompanyDrug

Kanghong Pharma Receives FDA Approval for KH631 Gene Therapy Trial

CompanyDeals

Saint Medical Raises Pre-Series B Funding for Structural Heart Disease Solutions

CompanyDrug

Frontier Biotechnologies Gains CDE Approval for FB2001 COVID-19 Inhalant Study

CompanyDrug

Alphamab Oncology and CSPC Announce Positive Phase II Data for KN026 in HER2-Positive Gastric Cancer

CompanyDrug

Kexing Pharma Receives Ethical Approval for Phase II Study of SHEN26 COVID-19 Drug

CompanyDrug

Kintor Pharma’s GT20029 Shows Positive Results in Phase I Study for Androgenetic Alopecia and Acne

CompanyDrug

FibroGen Sues Former Employees and Two Pharma Firms for Trade Secret Theft

CompanyDeals

JS InnoPharm and Strategia Holdings Form JSI Ventures in Boston